Yasuda, Hisataka <br/><br/>
[The mechanism of anti-RANKL antibody in the treatment of metabolic bone diseases including osteoporosis - possible applications of anti-RANKL antibody to the treatment of cancer patients].  [electronic resource] 

 -  Nihon yakurigaku zasshi. Folia pharmacologica Japonica   
 - 11-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0015-5691 
<br/><br/><label>Standard No.: </label>10.1254/fpj.153.11  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized<br/>Bone Resorption<br/>Denosumab--pharmacology<br/>Humans<br/>Osteoclasts--cytology<br/>Osteoporosis--therapy<br/>RANK Ligand--immunology